To improve anesthesia, focus on neuroscience and nociception, experts urge
A principled approach can lead to less need for drugs, especially opioids, Emery Brown and colleagues say.
A new way to manufacture small batches of biopharmaceuticals on demand
System can be rapidly reconfigured to produce a variety of protein drugs.
Abdul Latif Jameel Clinic for Machine Learning in Health at MIT aims to revolutionize disease prevention, detection, and treatment
A key part of the MIT Quest for Intelligence, J-Clinic builds on MIT expertise across multiple scientific disciplines.
New perspectives at the bench
Three MIT postdocs earn competitive Howard Hughes Medical Institute fellowships that support diversity in the sciences.
Artificial intelligence model “learns” from patient data to make cancer treatment less toxic
Machine-learning system determines the fewest, smallest doses that could still shrink brain tumors.
Sensor could help doctors select effective cancer therapy
Hydrogen peroxide-sensing molecule reveals whether chemotherapy drugs are having their intended effects.
A targeted approach to treating glioma
With new method, surgeons would remove tumor, then implant microparticles that attack remaining cancer cells.
Featured video: If the spacesuit fits
PhD student Richard Fineman is using wearable sensors to understand coordination and walking — and next-generation spacesuit design.
Scientists sharpen the edges of cancer chemotherapy
Whitehead team deploys CRISPR tools to better understand and uncover ways of improving methotrexate, a popular chemotherapy drug.
Three MIT-incubated ventures chosen for first Techstars Impact class
Base Operations, MDaaS Global, and Graviky Labs will head to Texas to be part of the first class at the new elite accelerator.
Nanoparticles give immune cells a boost
Drugs carried in cellular “backpacks” help T cells to destroy tumors.
![“What we discovered is, very little [Medicare] money is spent on people who we know with high probability are going to die in a short amount of time,” says Amy Finkelstein, a professor in MIT’s Department of Economics and co-author of a paper in the journal Science.](/sites/default/files/styles/term_page__news_article/public/images/201806/MIT-Health-Care-Spending.jpg?itok=uM3yQvcx)
The value of late-in-life health care spending
Study debunks notion that large chunks of Medicare go to futile end-of-life care.
3Q: Nancy Hopkins on the impact and potential of cancer prevention
Mechanism-based cancer prevention is poised to further decrease the numbers of U.S. cancer deaths, says MIT professor emerita.
Biologists discover how pancreatic tumors lead to weight loss
Shortfall of digestive enzymes can lead to tissue breakdown in early stages of pancreatic cancer.
Faster analysis of medical images
Algorithm makes the process of comparing 3-D scans up to 1,000 times faster.